Cirrhotic Ascites - Initial Management

Key Points

• Perform diagnostic paracentesis for new-onset ascites and promptly in hospitalized patients with cirrhosis and ascites.
• Ascitic PMN count of at least 250 cells/microL supports SBP and requires treatment.
• Sodium restriction plus spironolactone and furosemide is standard therapy for uncomplicated recurrent ascites.
• Large-volume paracentesis is first-line for tense symptomatic ascites.
• Give albumin after large-volume fluid removal according to guideline dosing.
• Hold or reduce diuretics when AKI, severe hyponatremia, hypotension, major potassium abnormalities, or volume-depletion encephalopathy develops.
• Refractory ascites should prompt transplant and selected TIPS evaluation.

Algorithm

1. Confirm ascites clinically or with ultrasound and perform diagnostic paracentesis.
2. Calculate SAAG and evaluate cell count, protein, and culture as indicated.
3. Treat SBP immediately when ascitic PMN count is at least 250 cells/microL.
4. For uncomplicated cirrhotic ascites, institute sodium restriction and diuretic therapy.
5. Use large-volume paracentesis for tense or highly symptomatic ascites.
6. Give albumin when large volumes are removed and monitor kidney function and sodium.
7. Stop or reduce diuretics when intolerance develops.
8. Refer refractory ascites for transplant evaluation and consideration of TIPS.

Clinical Synopsis & Reasoning

Ascites is a major decompensation event in cirrhosis and reflects portal hypertension, splanchnic vasodilation, renal sodium retention, and impaired effective arterial volume. New-onset ascites should not automatically be attributed to cirrhosis. Heart failure, malignancy, tuberculosis, pancreatitis, nephrotic disease, and other causes must be considered when the clinical context or fluid studies are atypical.

Diagnostic paracentesis is central. In a patient with new ascites, and in hospitalized patients with cirrhosis and ascites, send cell count with differential, albumin, total protein, and culture when infection is a concern. A serum-ascites albumin gradient of 1.1 g/dL or greater supports portal-hypertensive physiology. An ascitic neutrophil count of at least 250 cells/microL is diagnostic for SBP in the appropriate context and should trigger treatment even before culture finalization.

Severity is determined by more than abdominal size. Dyspnea, early satiety, umbilical hernia, hyponatremia, kidney dysfunction, hypotension, encephalopathy, and infection change management. Diuretic resistance or intolerance, frequent large-volume paracentesis, and progressive renal dysfunction indicate refractory ascites and should prompt evaluation for liver transplantation and, in selected patients, TIPS.

Treatment Strategy & Disposition

Restrict dietary sodium, generally to about 2 g per day, while preserving adequate calories and protein. Fluid restriction is not routinely necessary unless clinically important hypervolemic hyponatremia is present. For uncomplicated moderate ascites, use spironolactone with or without furosemide, often in a 100 mg to 40 mg ratio to help maintain potassium balance. Daily weight, creatinine, sodium, potassium, blood pressure, symptoms, and edema guide titration.

Tense or symptomatic large-volume ascites is treated most efficiently with therapeutic paracentesis. Give albumin after removal of more than about 5 liters to reduce post-paracentesis circulatory dysfunction, using guideline-based dosing. Stop or reduce diuretics with progressive AKI, severe hyponatremia, symptomatic hypotension, significant potassium disturbance, or worsening encephalopathy related to volume depletion.

Refractory ascites requires repeated large-volume paracentesis with albumin, transplant evaluation, and assessment for TIPS when there is no major contraindication such as severe heart failure, severe pulmonary hypertension, uncontrolled infection, or prohibitive encephalopathy risk. Avoid routine NSAIDs because they can worsen renal perfusion and sodium retention. Review ACE inhibitors, ARBs, and other blood-pressure-lowering medications carefully in advanced decompensated cirrhosis.

Epidemiology / Risk Factors

• Ascites is often the first major decompensating event in cirrhosis.
• AASLD notes that approximately 5 to 10 percent of compensated cirrhosis patients develop ascites each year.
• Development of ascites substantially worsens long-term survival and should trigger transplant consideration.
• SBP, HRS, hyponatremia, and hepatic hydrothorax are common associated complications.

Investigations

When to Hold or Reduce Diuretics

Pharmacology

Prognosis / Complications

• Diuretic-responsive ascites can often be controlled for extended periods with careful follow-up.
• Refractory ascites indicates advanced portal hypertension and worse survival.
• AKI and hyponatremia are strong markers of poor prognosis.
• Liver transplantation is definitive treatment for appropriate patients with decompensated cirrhosis.

Patient Education / Counseling

• Teach practical sodium restriction rather than simply telling patients to avoid all salt.
• Avoid NSAIDs and discuss any over-the-counter medication with the liver team.
• Track daily weight and report rapid gain, reduced urine output, dizziness, confusion, fever, or new abdominal pain.
• Explain that repeated paracentesis treats the fluid but not the underlying portal hypertension.
• Discuss transplant evaluation when ascites becomes recurrent or refractory.

Notes

The first procedure in new or hospitalized ascites is diagnostic paracentesis, not simply an increase in diuretics. Missing SBP is dangerous because infection may present without dramatic abdominal findings.

Refractory ascites is a disease-stage signal. Repeated drainage may keep a patient comfortable, but the need for frequent paracentesis should trigger discussion of transplant candidacy and other portal-hypertension strategies.

References

1. AASLD: Diagnosis, Evaluation and Management of Ascites, SBP and HRS — Link
2. AASLD: Paracentesis on Admission for Cirrhosis with Ascites — Link